Dieter H. Meier

Unterach, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.

Retraction Note: Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.

Journal: BMC neuroscience

Published: March 11, 2025

Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study.

Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: April 07, 2017

A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.

A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.

Journal: Brain : a journal of neurology

Published: February 12, 2016

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.

Journal: BMC neuroscience

Published: July 03, 2015

Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.

Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: April 27, 2015

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.

Journal: Stroke

Published: March 12, 2015

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.

Journal: Journal of experimental neuroscience

Published: January 01, 2015

Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.

Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.

Journal: Stem cell research

Published: December 23, 2014

Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke.

Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke.

Journal: Stroke

Published: May 23, 2013

Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling.

Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling.

Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

Published: March 05, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026